治疗耐药性抑郁症中的miRNAs:系统性审查
Lun Cai1, Jingwen Xu1, Jie Liu1
1Department of Neurology, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi University of Chinese Medicine, Nanning, 530023, People's Republic of China.
Molecular biology reports
|May 10, 2024
概括
微RNAs (miRNAs) 是治疗耐药性抑郁症 (TRD) 病原体的关键. 了解miRNA在炎症,血清素运输和突触可塑性中的作用可能会导致新的TRD诊断和治疗方法.
科学领域:
- 分子生物学分子生物学
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
背景情况:
- 耐治疗抑郁症 (TRD) 影响越来越多的患者,诊断和治疗进展有限.
- 目前尚不完全了解TRD的潜在致病机制,这凸显了对新型研究途径的需求.
- 微RNAs (miRNAs) 越来越多地被认为是它们在疾病发病过程中的调节作用,包括TRD.
研究的目的:
- 系统地审查miRNAs在治疗耐药抑郁症 (TRD) 病理生理学的作用.
- 阐明miRNAs对TRD的贡献的特定机制.
- 在TRD中确定未来诊断和治疗策略的潜在miRNA目标.
主要方法:
- 在PubMed,Web of Science,Cochrane Library和Embase数据库中进行了系统的文献搜索.
- 关键词包括"耐治疗抑郁症"",耐药抑郁症"和"miRNAs".
- 审查了2024年2月之前发表的精选文章,以对miRNA参与TRD的发现进行整理.
主要成果:
- 微RNAs (miRNAs) 通过炎症反应 (例如,miR-155,miR-146a) 参与TRD病原发生.
- 特定的miRNAs影响血清素 (5-HT) 运输过程,影响TRD发育 (例如,miR-674,miR-133a).
- miRNAs调节突触可塑性,这是TRD的一个关键因素 (例如,has-miR-335-5p,let-7b).
结论:
- 微RNAs (miRNAs) 在治疗耐药性抑郁症 (TRD) 的发病过程中发挥着重要作用.
- 对miRNA表达和相互作用的进一步调查可以加深对TRD分子机制的理解.
- 鉴定TRD涉及的特定miRNA可能为新型诊断标记物和治疗干预措施铺平道路.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
226
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
226
01:18Depression: Overview
241
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
241
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
375
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
375
01:25Antidepressant Drugs: Overview
453
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
453